Duarte, CALIFORNIA5 Active Studies

Ovarian Cancer Clinical Trials in Duarte, CALIFORNIA

Find 5 actively recruiting ovarian cancer clinical trials in Duarte, CALIFORNIA. Connect with local research sites and explore new treatment options.

5
Active Trials
5
Sponsors
1,796
Enrolling

Recruiting Ovarian Cancer Studies in Duarte

RecruitingDuarte, CALIFORNIANCT04590326

A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab

This study is researching an investigational drug called REGN5668 : * alone or, * combined with cemiplimab (also known as REGN2810) or, * combined with both cemiplimab and fianlimab (also known as RE...

612 participants
Regeneron Pharmaceuticals
View Study Details
RecruitingDuarte, CALIFORNIANCT03772028

Primary Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy (HIPEC)

stage III epithelial ovarian cancer randomizing between primary cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy...

538 participants
The Netherlands Cancer Institute
View Study Details
RecruitingDuarte, CALIFORNIANCT05659381

Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer

Patients will be registered prior to, during or at the completion of neoadjuvant chemotherapy (Paclitaxel 175 mg/m2 IV over 3 hours and Carboplatin AUC 6 IV on Day 1 every 21 days for 3-4 cycles). Reg...

230 participants
GOG Foundation
View Study Details
RecruitingDuarte, CALIFORNIANCT06690775

CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.

A Phase 2 study to evaluate the safety and efficacy of TORL-1-23 in patients with advanced ovarian cancer....

230 participants
TORL Biotherapeutics, LLC
View Study Details
RecruitingDuarte, CALIFORNIANCT05281471

Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)

The OnPrime study is a multi-center, randomized open-label phase 3 study evaluating the safety and efficacy of Olvi-Vec followed by platinum-doublet chemotherapy and bevacizumab compared to the Active...

186 participants
Genelux Corporation
View Study Details

About Ovarian Cancer Clinical Trials in Duarte

Ovarian cancer originates in the ovaries or fallopian tubes and is often called a "silent killer" due to subtle early symptoms. It is the fifth leading cause of cancer death among women. Treatment typically involves surgery and chemotherapy, with newer targeted therapies showing promise.

There are currently 5 ovarian cancer clinical trials recruiting participants in Duarte, CALIFORNIA. These studies are seeking a combined 1,796 participants. Research is being sponsored by Regeneron Pharmaceuticals, The Netherlands Cancer Institute, GOG Foundation and 2 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Ovarian Cancer Clinical Trials in Duarte — FAQ

Are there ovarian cancer clinical trials in Duarte?

Yes, there are 5 ovarian cancer clinical trials currently recruiting in Duarte, CALIFORNIA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Duarte?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Duarte research site will contact you about next steps.

Are clinical trials in Duarte free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Duarte studies also compensate for your time and travel.

What ovarian cancer treatments are being tested?

The 5 active trials in Duarte are testing new therapies including novel drugs, biologics, and treatment approaches for ovarian cancer.

Data updated March 2, 2026 from ClinicalTrials.gov